Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-22 Sale |
2023-11-27 6:18 pm |
10x Genomics Inc. | TXG | Wilbur James Chief Commercial Officer |
3,464 | $43.34 | $150,118 | 83,342 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-22 4:30 pm |
10x Genomics Inc. | TXG | Wilbur James Chief Commercial Officer |
14,718 | $42.09 | $619,494 | 86,806 (Direct) |
View |
| 2023-08-22 Sale |
2023-08-24 5:08 pm |
10x Genomics Inc. | TXG | Wilbur James Chief Commercial Officer |
9,699 | $45.78 | $444,031 | 101,253 (Direct) |
View |
| 2023-05-23 Sale |
2023-05-25 5:49 pm |
10x Genomics Inc. | TXG | Wilbur James Chief Commercial Officer |
316 | $55.07 | $17,401 | 110,952 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-21 Option Award |
2023-03-23 6:25 pm |
N/A 2033-03-21 |
10x Genomics Inc. | TXG | Wilbur James Chief Commercial Officer |
21,833 | $0 | 132,227 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 5:32 pm |
N/A 2032-09-14 |
10x Genomics Inc. | TXG | Wilbur James Chief Commercial Officer |
335,435 | $0 | 335,435 (Direct) |
View |